Drug touted by Trump as COVID-19 treatment tied to increased risk of death: study

US

FILE PHOTO: A nurse shows a Hydroxychloroquine pill, amid the coronavirus disease (COVID-19) outbreak, at Nossa Senhora da Conceicao hospital in Porto Alegre, Brazil, April 23, 2020. REUTERS/Diego Vara

(Reuters) – Malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking, was tied to increased risk of death in a study in 96,000 COVID-19 patients, according to a paper published in the Lancet.

The study found here that people treated with hydroxychloroquine, or the closely related drug chloroquine, had higher risk of in-hospital death when compared to those who had not been given the drug.

Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty

Products You May Like

Articles You May Like

Prepare to study in Canada
Study permit: Who can apply
Ukrainian Immigration Surge Expected in British Columbia As Emergency Travel Program Ends
Canada Issues 1,500 Express Entry Invitations to Apply For French-Language Speakers
Alberta Tourism and Hospitality Stream Sees High Applicant Numbers
Ontario to Reserve 96 Per Cent of Foreign Student Applications to its Public Colleges and Universities
Nurses Can Immigrate To Canada More Quickly By Using PASS Program

Leave a Reply

Your email address will not be published. Required fields are marked *